For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230629:nRSc3046Ea&default-theme=true
RNS Number : 3046E Revolution Beauty Group PLC 29 June 2023
For Immediate Release 29 June 2023
REVOLUTION BEAUTY GROUP PLC
("Revolution Beauty", the "Group" or the "Company")
Director dealings
Revolution Beauty Group plc (AIM: REVB), the multi-channel mass beauty
innovator, has been notified that Bob Holt, Chief Executive Officer of the
Company, purchased 1,000,000 ordinary shares of £0.01 each ("Ordinary
Shares") on 28 June 2023 at a price of 26p per Ordinary Share. Following this
purchase, he now holds 1,000,000 Ordinary Shares representing 0.3% of the
current Issued Share Capital of the Company
The Company has also been notified that Derek Zissman, Non-Executive Chairman
of the Company purchased 100,000 ordinary shares of £0.01 each ("Ordinary
Shares") on 28 June 2023 at a price of 30.5p per Ordinary Share. Following
this purchase, he now holds 130,000 Ordinary Shares representing 0.04% of the
current Issued Share Capital of the Company
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them, provided
in accordance with the requirements of the UK Market Abuse Regulation
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Robert Holt
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Revolution Beauty Group plc
b) LEI 21380083TTJWXK677H17
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of £0.01
Identification code
ISIN: GB00BP7L1T61
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volume(s) Price(s) Volume(s)
26p 1,000,000
d) Aggregated information N/A - single transaction
- Aggregated volume
- Price
e) Date of the transaction 28 June 2023
f) Place of the transaction London Stock Exchange, AIM
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Derek Zissman
2 Reason for the notification
a) Position/status Non-Executive Chairman
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Revolution Beauty Group plc
b) LEI 21380083TTJWXK677H17
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of £0.01
Identification code
ISIN: GB00BP7L1T61
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volume(s) Price(s) Volume(s)
30.5p 100,000
d) Aggregated information N/A - single transaction
- Aggregated volume
- Price
e) Date of the transaction 28 June 2023
f) Place of the transaction London Stock Exchange, AIM
For further information please contact:
Revolution Beauty Investor Relations
Bob Holt / Elizabeth Lake Investor.Relations@revolutionbeautyplc.com
Joint Corporate Brokers
Zeus (NOMAD): Nick Cowles /Jamie Peel /Jordan Warburton Tel: +44 (0) 161 831 1512
Liberum: Clayton Bush / Edward Thomas / Miquela Bezuidenhoudt
Tel: +44 (0) 203 100 2222
Media enquiries:
Headland Consultancy Tel: +44 (0)20 3805 4822
Matt Denham / Will Smith / Antonia Pollock Revolutionbeauty@headlandconsultancy.com
- Ends -
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHGZGZVMRGGFZZ